No label defined (Q32506)

From lgbtDB
Revision as of 03:06, 16 November 2024 by Superraptor (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
No description defined
  • Reducing intersectional stigma among transgender women in Brazil to promote uptake of HIV testing and PrEP: study protocol for a randomised controlled trial of Manas por Manas.
Language Label Description Also known as
English
No label defined
No description defined
  • Reducing intersectional stigma among transgender women in Brazil to promote uptake of HIV testing and PrEP: study protocol for a randomised controlled trial of Manas por Manas.

Statements

title
Reducing intersectional stigma among transgender women in Brazil to promote uptake of HIV testing and PrEP: study protocol for a randomised controlled trial of Manas por Manas. (English)
1 reference
stated in
PubMed
abstract
Globally, transgender ('trans') women experience extreme social and economic marginalisation due to intersectional stigma, defined as the confluence of stigma that results from the intersection of social identities and positions among those who are oppressed multiple times. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
1
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
Among trans women, gender-based stigma intersects with social positions such as engagement in sex work and substance use, as well as race-based stigma to generate a social context of vulnerability and increased risk of HIV acquisition. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
2
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
In Brazil, trans women are the 'most at-risk' group for HIV, with 55 times higher estimated odds of HIV infection than the general population; further, uptake of HIV testing and pre-exposure prophylaxis (PrEP) among trans women is significantly lower than other at-risk groups. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
3
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
Through extensive formative work, we developed Manas por Manas, a multilevel intervention using HIV prevention strategies with demonstrated feasibility and acceptability by trans women in Brazil, to address intersectional stigma and increase engagement in the HIV prevention continuum. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
4
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
We are conducting a two-arm randomised wait-list controlled trial of the intervention's efficacy in São Paulo, Brazil, to improve uptake of HIV testing and PrEP among transgender women (N=400). (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
5
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
The primary outcomes are changes in HIV testing (self-testing and clinic based), changes in PrEP uptake and changes in PrEP persistence at baseline and follow-up assessment for 12 months at 3-month intervals. (English)
source label
METHODS AND ANALYSIS (English)
subsection NLM category
methods section
series ordinal
6
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
This study was approved by University of California, San Francisco Institutional Review Board (15-17910) and Comissão Nacional de Ética em Pesquisa (Research Ethics National Commission, CAAE: 25215219.8.0000.5479) in Brazil. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
7
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
Participants provided informed consent before enrolment. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
8
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
We are committed to collaboration with National Institutes of Health officials, other researchers, and health and social services communities for rapid dissemination of data and sharing of materials. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
9
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
The results will be published in peer-reviewed academic journals and scientific presentations. (English)
source label
ETHICS AND DISSEMINATION (English)
subsection NLM category
background section
series ordinal
10
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
NCT03081559. (English)
source label
TRIAL REGISTRATION NUMBER (English)
subsection NLM category
background section
series ordinal
11
copyright statement
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. (English)
publisher
BMJ
date copyrighted
2024
rights holder
Jae Sevelius
Maria Veras
Q32499
Q32500
Q32501
Katia Cristina Bassichetto
Q32502
Q32503
1 reference
stated in
PubMed
date published
21 June 2024
1 reference
stated in
PubMed
date issued
21 June 2024
1 reference
stated in
PubMed
author
volume
14
1 reference
stated in
PubMed
issue
6
1 reference
stated in
PubMed
page(s)
e076878
1 reference
stated in
PubMed
page start
e076878
1 reference
stated in
PubMed
conflict-of-interest statement
Competing interests: None declared. (English)
series ordinal
1
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q32506&oldid=190951"